A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently lost in various forms of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research